Table 1.
Cluster association for each group detected in the clustering analyses of both DVJ trials and the SLD trial. Each column represents the number of subjects in the specified group from the first trial (left) that were associated with the specified group in the second trial (top) and their percentage of the total number of subjects. Majority associations are in bold. For example, 86.5% of subjects grouped in C2-Risky NMR on the first DVJ trial were grouped into C2-Risky NMR on the second DVJ trial (218/252).
| DVJ Trial 2 |
||||||
|---|---|---|---|---|---|---|
| N | C1-High NMR | C2-Risky NMR | C3-Low NMR | |||
| DVJ Trial 1 | C1-High NMR | 244 | 136 (55.7%) | 82 (33.6%) | 26 (10.7%) | |
| C2-Risky NMR | 252 | 19 ( 7.5%) | 218 (86.5%) | 15 ( 6.0%) | ||
| C3-Low NMR | 284 | 53 (18.7%) | 137 (48.2%) | 94 (36.4%) | ||
| Total | 780 | 208 (26.7%) | 437 (56.0%) | 135 (17.3%) | ||
| SLD Trial 1 |
||||||
| N | C1 | C2 | C3 | C4 | ||
| DVJ Trial 1 | C1-High NMR | 92 | 22 (23.9%) | 14 (15.2%) | 21 (22.8%) | 35 (38.0%) |
| C2-Risky NMR | 131 | 22 (16.8%) | 32 (24.4%) | 21 (16.0%) | 56 (42.7%) | |
| C3-Low NMR | 129 | 26 (20.2%) | 35 (27.1%) | 35 (27.1%) | 33 (25.6%) | |
| Total | 352 | 70 (19.9%) | 81 (23.0%) | 77 (21.9%) | 124 (35.2%) | |
| SLD Trial 1 |
||||||
| N | C1 | C2 | C3 | C4 | ||
| DVJ Trial 2 | C1-High NMR | 82 | 11 (13.4%) | 18 (22.0%) | 15 (18.3%) | 38 (46.3%) |
| C2-Risky NMR | 214 | 42 (19.6%) | 54 (25.2%) | 43 (20.1%) | 75 (35.0%) | |
| C3-Low NMR | 56 | 17 (30.4%) | 9 (16.1%) | 19 (33.9%) | 11 (19.6%) | |
| Total | 352 | 70 (19.9%) | 81 (23.0%) | 77 (21.9%) | 124 (35.2%) | |